Your browser doesn't support javascript.
loading
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
Nasioudis, Dimitrios; Gysler, Stefan; Latif, Nawar; Cory, Lory; Giuntoli, Robert L; Kim, Sarah H; Simpkins, Fiona; Martin, Lainie; Ko, Emily M.
Affiliation
  • Nasioudis D; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA. Electronic address: dimitrios.nasioudis@pennmedicine.upenn.edu.
  • Gysler S; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Latif N; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Cory L; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Giuntoli RL; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Kim SH; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Simpkins F; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Martin L; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
  • Ko EM; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Gynecol Oncol ; 180: 1-5, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38029652

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Uterine Neoplasms / Carcinosarcoma / Uterine Cervical Neoplasms / Endometrial Neoplasms / Carcinoma, Endometrioid / Genital Neoplasms, Female Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Uterine Neoplasms / Carcinosarcoma / Uterine Cervical Neoplasms / Endometrial Neoplasms / Carcinoma, Endometrioid / Genital Neoplasms, Female Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2024 Type: Article